Company set to present data from two preclinical R&D programs at the Society for NeuroScience's Annual Conference
Data supports expanding indications for bioelectronics platform
[fa icon="calendar'] November 11, 2016 / posted in Bioelectronics, Clinical Trials, Neurostimulation, Urinary Incontinence, R&D, Implantable Devices, Innovation
A trial at the U of M is helping stroke victims regain their strength
[fa icon="calendar'] December 31, 2015 / posted in Stroke, Vagal Nerve Stimulation (VNS), Clinical Trials, MicroTransponder
Minneapolis, Dec. 30, 2015 -- At just 52-years-old, Charles Madson suffered a stroke. In the year since, he's relearned to talk and walk, and now he has jumped at the chance to be part of medical trial at the University of Minnesota – a trial that is showing some surprising results.
MicroTransponder Clinical Trial Results Published in Stroke After Company Completes a $5.5M Round of Funding
[fa icon="calendar'] December 11, 2015 / posted in Stroke, Vagal Nerve Stimulation (VNS), Clinical Trials, MicroTransponder
The Prestigious American Heart Association Journal Stroke Has Published the Results of the Paired VNS Therapy for Stroke Patients With Reduced Upper Limb Mobility
DALLAS, TX--(Marketwired - December 10, 2015) - MicroTransponder, Inc., (www.microtransponder.com) a privately
MicroTransponder Clinical Trial Results Published in Stroke after Company Completes a $5.5M Round of Funding
[fa icon="calendar'] December 10, 2015 / posted in Stroke, Vagal Nerve Stimulation (VNS), Clinical Trials, MicroTransponder, Grants & Funding
Dec. 9, 2015 -- MicroTransponder, Inc., (www.microtransponder.com) a privately-held medical device company, is pleased to announce that its successful stroke rehabilitation clinical trial has been published in the prestigious academic journal Stroke. The manuscript
MicroTransponder Invited to Present Stroke Clinical Trial Results at the International Stroke Conference, with U.S. Stroke Study to Follow
[fa icon="calendar'] February 5, 2015 / posted in Stroke, Clinical Trials, MicroTransponder
DALLAS, Texas – February 4, 2015 – MicroTransponder, Inc., (www.microtransponder.com) a privately-held medical device company is pleased to announce the successful completion of its 20-patient stroke trial using the Vivistim® System. The results of this ground breaking
NIH announces recruitment for clinical trial to test new tinnitus treatment device: Multi-center trial offers hope for millions of Americans with severe tinnitus
[fa icon="calendar'] March 7, 2014 / posted in Tinnitus, Vagal Nerve Stimulation (VNS), Clinical Trials, MicroTransponder
Researchers supported by the National Institutes of Health are launching a clinical trial to test a device that uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus, a persistent buzzing or ringing sound in
Nexeon MedSystems, Inc., Announces Enrollment of First Patient in Feasibility Trial for Novel Prohealing Stent System
[fa icon="calendar'] October 8, 2008 / posted in Dr. Mark Bates, Stents, Clinical Trials, WVU School of Medicine
New Class of Stent Could Offer Non-DES Solution to Restenosis and Late Stent Thrombosis
CHARLESTON, W.Va. & CARLSBAD, Calif.--(BUSINESS WIRE)--Nexeon MedSystems, Inc., a developer of medical technology for the treatment of cardiovascular disease, announced today that t